Why Do Some People Believe Synthetic Cannabinoids Help With Stress in Europe? | Full Explainer

Across Europe, a troubling pattern has emerged: a growing number of people turn to synthetic cannabinoids — often sold as “Spice,” “K2,” or “herbal incense” — with the belief that these substances can relieve stress, anxiety, and mental tension. But why do some people believe synthetic cannabinoids help with stress in Europe, and is there any truth to this belief?

The short answer is: the belief exists, but it is built on dangerous misconceptions. This comprehensive guide explores the psychological, chemical, and social reasons why do some people believe synthetic cannabinoids help with stress in Europe, and what the science actually tells us.

⚠️ Important Health Warning

Synthetic cannabinoids are not a safe or effective treatment for stress. They are associated with severe adverse events including psychosis, seizures, cardiac arrest, and death. If you are struggling with stress or mental health, please seek qualified professional support.

47

New psychoactive substances first reported in Europe in 2024

20

New cannabinoids identified in Europe in 2024 alone

22

EU Member States that have listed HHC as a controlled drug

4.1%

European survey respondents who reported past-year synthetic cannabinoid use

What Are Synthetic Cannabinoids?

Synthetic cannabinoids (SCs) are man-made chemicals designed to mimic the effects of THC (tetrahydrocannabinol), the active compound in natural cannabis. Unlike plant-based cannabis, these substances are laboratory-produced and sprayed onto dried plant material or dissolved into liquids for vaping.

They are often labelled “herbal incense,” “potpourri,” or “research chemicals” to circumvent legal classification — a deliberate marketing strategy that makes them seem harmless to uninformed users.

Synthetic cannabinoid products are often packaged as “herbal incense” or “potpourri” to avoid legal detection. Source: Public domain / Wikipedia

According to the European Union Drugs Agency (EUDA), synthetic cannabinoids first emerged in European drug markets during the early 2000s and became widely accessible throughout the 2010s. Today they represent one of the largest categories of new psychoactive substances (NPS) monitored by the EU Early Warning System.why do some people believe synthetic cannabinoids help with stress in Europe

Types of Synthetic Cannabinoids Found in Europe

🧪

Classical SCs (JWH series)e.g. JWH-018, JWH-122 — the original synthetic cannabinoids from 2000s

🧬

Semi-Synthetic Cannabinoidse.g. HHC, HHC-P — chemically modified forms of natural cannabinoids, widely available since 2022

💨

Vape Liquids with SCsIncreasingly popular delivery method, especially among younger users in Europe

🍬

Edibles and GummiesGrowing concern — in 2024 Hungary reported 30 acute poisonings linked to SC-containing gummies

Why Do Some People Believe Synthetic Cannabinoids Help With Stress in Europe?

Understanding why do some people believe synthetic cannabinoids help with stress in Europe requires examining both the pharmacological effects and the social context surrounding their use. This belief is not entirely baseless from a subjective standpoint — but it is deeply misleading and dangerous.

1. They Activate the Brain’s Stress-Response System — Briefly

Synthetic cannabinoids bind to the same CB1 and CB2 cannabinoid receptors in the brain that natural cannabis does. When these receptors are activated, they can produce a short-lived sense of calm, reduced inhibition, or detachment from immediate worries. For someone experiencing acute stress or anxiety, this temporary numbing effect can feel like relief.

This is the primary pharmacological reason why do some people believe synthetic cannabinoids help with stress in Europe: they do produce a fleeting psychoactive dampening of stress responses — but at a far greater intensity and unpredictability than natural cannabis.

2. Marketing as “Legal” and “Natural” Alternatives

A key driver of the belief that these substances are helpful is how they are marketed. Products are often sold with labels such as “not for human consumption,” “herbal blend,” or “legal high.” In countries where natural cannabis remains heavily restricted, many users — particularly young people — perceive synthetic cannabinoids as a risk-free or legally permissible substitute.

“Products sometimes mis-sold, consumers may be unaware of what they are taking and subject to greater health risks, including potentially fatal poisoning.” — European Drug Report 2024

3. Social Proof and Peer Influence

Social environments play a powerful role. When peers report feeling “calmer” or “less stressed” after using synthetic cannabinoids, these anecdotal accounts spread rapidly — especially in online communities, prisons, and social housing environments where these drugs are disproportionately prevalent. This social reinforcement perpetuates the false belief that synthetic cannabinoids help with stress in Europe.

4. Accessibility and Low Cost

Stress often correlates with financial hardship. Synthetic cannabinoids are typically cheaper than both natural cannabis and prescription medications. Their availability in corner shops, online, and via informal networks makes them a go-to option for people under economic pressure who are also experiencing mental health difficulties.

Stress, anxiety, and financial pressure are among the key contextual factors that drive individuals toward synthetic cannabinoids as perceived coping tools. can i ask why do some people believe synthetic cannabinoids help with stress in Europe

The Major Misconceptions That Drive Use

The question of why do some people believe synthetic cannabinoids help with stress in Europe cannot be answered without addressing the misconceptions that underpin this belief. Let’s break the most common ones down side by side.

❌ Myth

“They are just like cannabis — natural and safe.”

✅ Fact

Synthetic cannabinoids are entirely lab-made, are full agonists of cannabinoid receptors (binding far more powerfully than THC), and carry dramatically higher risks of psychosis, seizures, and cardiac arrest.

❌ Myth

“They are legal, so they must be safe.”

✅ Fact

Legal status does not equal safety. Most are now controlled across Europe. New variants are continuously developed to evade bans, often with unknown and potentially lethal effects.

❌ Myth

“If I feel less stressed, they must be working.”

✅ Fact

The brief sedative effect masks a serious neurotoxic process. The short-term “calm” is followed by heightened anxiety, paranoia, and worsened mental health over time.

❌ Myth

“They are not addictive like other drugs.”

✅ Fact

Synthetic cannabinoids cause psychological and physical dependency. Withdrawal is often more severe than from natural cannabis, involving intense cravings, insomnia, severe anxiety, and tremors.

Short-Term Effects That Make Them Seem Attractive

Another layer of understanding why do some people believe synthetic cannabinoids help with stress in Europe comes from looking at the actual short-term effects users initially experience. These effects create a powerful (but false) impression of stress relief.

Initial Effects — The “Appeal Window”

😌

Temporary RelaxationBrief sedation and muscle relaxation give users a sense that tension is dissolving

🌀

Altered PerceptionDistorted sense of time and detachment from immediate problems can feel like escape

😂

Euphoria / LaughterSpontaneous mood elevation creates a short-term feeling of well-being

💤

DrowsinessSedation can mimic the relief of falling asleep after a period of tension

What Follows — The Reality

⚠️ The Dangerous Truth About Short-Term Effects

The initial “calming” phase is quickly followed by — or occurs simultaneously with — a range of dangerous effects: severe agitation, rapid heart rate (tachycardia), paranoia, psychosis, chest pain, nausea, vomiting, seizures, and in extreme cases, cardiac arrest or stroke. These are not rare outcomes; they are commonly documented across European emergency rooms.

💔

Cardiac ToxicityTachycardia, arrhythmias, myocardial infarction, and cardiac arrest are well-documented

🧠

PsychosisSevere paranoia, hallucinations, and dissociation — particularly in those with pre-existing mental health conditions

⚡

SeizuresNeurological complications can occur even on first use, especially with high-potency compounds

🫁

Respiratory DepressionStudies report respiratory failure requiring ventilation in 12% of severe pediatric cases

The Science: What Actually Happens in the Brain

To fully understand why do some people believe synthetic cannabinoids help with stress in Europe, we need to look at the neuroscience. This also explains why the belief, while initially rooted in a real experience, leads users into a dangerous cycle.

How the Endocannabinoid System Works

The human body has a natural endocannabinoid system (ECS) that regulates mood, stress response, appetite, sleep, and pain. Key receptors — CB1 (concentrated in the brain) and CB2 (concentrated in the immune system) — are the targets of both natural cannabinoids and synthetic ones.

The endocannabinoid system governs stress regulation, mood, and pain. Synthetic cannabinoids disrupt this system far more aggressively than natural cannabis.

Why Synthetic Cannabinoids Are Different — and More Dangerous

Natural THC is a partial agonist of CB1 receptors — it activates them partially. Synthetic cannabinoids are full agonists — they activate these receptors completely and often far more intensely. This distinction is critical:

🔬 Key Science Fact

Full agonism of CB1 receptors by synthetic cannabinoids triggers downstream signalling pathways — including oxidative stress, neuroinflammation, and apoptosis (cell death) — that do not occur to the same degree with natural cannabis. This is why the same perceived “relaxation” leads to far more dangerous physiological consequences.

The Stress Paradox

Here is the central paradox: synthetic cannabinoids activate the body’s stress-dampening system, but in doing so, they simultaneously trigger inflammatory and oxidative stress responses in the brain. What users interpret as “feeling less stressed” is in fact the brain experiencing a kind of neurochemical overload — one that progressively damages the mental health system they are trying to repair.

The European Landscape: Scale of the Problem

Understanding the full picture of why do some people believe synthetic cannabinoids help with stress in Europe requires context about just how widespread this issue has become on the continent.

The EUDA European Drug Report 2024 highlights synthetic cannabinoids as among the most significant emerging drug threats across EU member states. Source: EUDA

Key European Statistics (2024–2025)

Prisons: The Highest-Risk Environment

One of the most concerning patterns in European data is the disproportionate prevalence of synthetic cannabinoid use in prison environments. The combination of stress, limited access to natural cannabis, and the fact that SCs can often pass undetected in standard drug tests makes prisons a hotspot for their use — and for the misconception that they help manage the psychological pressures of incarceration.

📌 Important Context

The belief that synthetic cannabinoids help with stress in Europe is particularly entrenched in prison populations, where high psychological stress, limited mental health support, and the drugs’ ability to evade detection in urine tests combine to drive use.

Why Synthetic Cannabinoids Are Far More Dangerous Than Cannabis

This is the most critical piece of information for anyone asking why do some people believe synthetic cannabinoids help with stress in Europe: the belief is based on a false equivalence with cannabis that is chemically and medically unjustified.

Who Uses Synthetic Cannabinoids and Why in Europe?

Research from the 2021 European Web Survey on Drugs (EWSD), involving 48,427 respondents from 22 European countries, provides the most comprehensive insight into why do some people believe synthetic cannabinoids help with stress in Europe at a population level.

Key Finding: SCs Serve Different Needs Than Cannabis

Crucially, the research revealed that stress reduction is actually a more prominent motive for cannabis use than for synthetic cannabinoid use. This is a vital piece of evidence: users of SCs are often not primarily motivated by stress relief — they are driven by pain management, curiosity, or simply by what is available when natural cannabis is not.

📊 Research Finding

According to a 2025 study in the International Journal of Mental Health and Addiction, “the motives of reducing stress, getting high, and enhancing performance and curiosity proved to be more pronounced in the case of cannabis use than in the case of the use of SCs.” This challenges the widely held assumption about why do some people believe synthetic cannabinoids help with stress in Europe — the belief may be more perception than practice.

Vulnerable Groups Most Affected

👨‍🦱

Young Adults (18–35)Highest prevalence of SC use; most exposed to marketing of “legal highs”

🏛️

Prison PopulationsHigh psychological stress + limited access to natural cannabis + undetectable in basic drug tests

😟

Those with Mental Health ConditionsAnxiety, depression, and PTSD sufferers may seek self-medication — but SCs worsen these conditions

💸

Economically Vulnerable IndividualsLow cost and accessibility make SCs appealing during financial hardship

What to Do: Safer Ways to Manage Stress in Europe

Having understood why do some people believe synthetic cannabinoids help with stress in Europe, it is essential to redirect toward genuinely effective and safe alternatives.

Evidence-Based Stress Management Alternatives

🧘

Mindfulness & CBTCognitive-behavioural therapy and mindfulness are proven, lasting treatments for stress and anxiety

🏃

Physical ExerciseRegular aerobic activity significantly reduces cortisol (the stress hormone) with no dangerous side effects

🩺

GP / Mental Health ServicesSpeak to your general practitioner — effective, evidence-based treatments for stress and anxiety are available free via national health systems in most European countries

📞

Drug HelplinesIf you or someone you know is using synthetic cannabinoids, contact your national drug helpline. Emergency: call 112 across Europe if there is a medical emergency.

✅ If You Are Struggling

Across Europe, free, confidential drug and mental health support services are available. Visit your national health authority website or call the emergency services (112) immediately if someone is experiencing a severe reaction to synthetic cannabinoids. You are not alone, and effective help exists.

If Someone Has Taken Synthetic Cannabinoids — Emergency Guidance

Signs of a serious reaction include: chest pain, difficulty breathing, seizures, extreme confusion, loss of consciousness, or severe paranoia. Call 112 immediately. Do not leave the person alone. Tell emergency services what was taken if known. Do not give food or water to someone who is not fully conscious.

Frequently Asked Questions (FAQ)

These questions are structured to match common searches and AI-referenced queries on synthetic cannabinoids and stress in Europe.

Q: Why do some people believe synthetic cannabinoids help with stress in Europe?

Some users believe synthetic cannabinoids help with stress because they bind to CB1 and CB2 receptors in the brain — the same receptors involved in the body’s natural stress regulation — producing a brief, initial sense of calm or detachment. Their low cost, wide availability, and marketing as “legal” or “herbal” alternatives to cannabis also make them seem like accessible stress-relief tools. However, this perceived benefit is temporary, misleading, and followed by far more serious psychological and physical harms.

Q: Are synthetic cannabinoids safer than natural cannabis for managing stress?

No. Synthetic cannabinoids are significantly more dangerous than natural cannabis. They are full agonists of cannabinoid receptors, activating them far more intensely than THC. This leads to a much higher risk of psychosis, seizures, cardiac complications, and fatal poisonings. The European Union Drugs Agency (EUDA) classifies them as a serious and growing public health threat across Europe.

Q: Do synthetic cannabinoids actually work for stress or anxiety?

No. While users may experience a brief initial sense of relaxation, research consistently shows that synthetic cannabinoids worsen anxiety and mental health outcomes with continued use. The 2025 European Web Survey on Drugs found that stress reduction is actually a more prominent motive behind natural cannabis use than synthetic cannabinoid use, suggesting that even users of SCs don’t primarily use them for stress — and that the belief they are stress-relievers is largely a misconception driven by availability and marketing.

Q: What are the short-term effects of synthetic cannabinoids?

Initial short-term effects include temporary relaxation, euphoria, altered perception, and drowsiness — which create the false impression of stress relief. These are rapidly followed (or accompanied) by dangerous effects: severe agitation, paranoia, rapid heart rate, chest pain, psychosis, nausea, vomiting, seizures, and in serious cases, cardiac arrest or stroke. These adverse effects can occur even on first use.

Q: What is the legal status of synthetic cannabinoids in Europe in 2025?

Most synthetic cannabinoids are now controlled substances across Europe. The EU Early Warning System identified 20 new cannabinoids in Europe in 2024 alone. Semi-synthetic cannabinoids like HHC have been listed as controlled drugs in at least 22 EU Member States. New compounds continue to be developed to evade existing bans. Legal status varies by country and continues to evolve rapidly.

Q: Who is most at risk from synthetic cannabinoids in Europe?

The most vulnerable groups include young adults (18–35), prison populations (where SCs are used disproportionately due to stress, limited access to cannabis, and undetectability in standard drug tests), people with pre-existing mental health conditions including anxiety and depression, economically vulnerable individuals attracted by low cost, and people who unknowingly consume cannabis adulterated with synthetic cannabinoids.

Q: Can synthetic cannabinoids cause addiction?

Yes. Synthetic cannabinoids can cause both psychological and physical dependency. Withdrawal symptoms include severe anxiety, mood swings, intense cravings, insomnia, nausea, sweating, and tremors — and these are often more severe than withdrawal from natural cannabis. Professional medical support is recommended for anyone trying to stop using synthetic cannabinoids.

Q: Why do synthetic cannabinoids seem stronger than regular cannabis?

Synthetic cannabinoids are full agonists of CB1 and CB2 receptors, meaning they bind and activate these receptors completely and intensely. Natural THC, by contrast, is only a partial agonist. This difference in binding mechanism explains why SCs produce far more intense and unpredictable effects — including severe psychosis and cardiovascular emergencies — even at small doses.

Q: What should I do if someone I know has taken synthetic cannabinoids and is having a bad reaction?

Call emergency services (112 across Europe) immediately if the person is experiencing chest pain, severe confusion, seizures, difficulty breathing, or loss of consciousness. Stay with them, keep them calm, do not give food or water if they are not fully conscious, and inform paramedics of what was taken. Do not leave them alone under any circumstances.

Conclusion: Belief vs. Reality

The question of why do some people believe synthetic cannabinoids help with stress in Europe has a multi-layered answer: it is driven by a brief but real pharmacological effect, reinforced by misleading marketing, social proof, low cost, and easy availability — and amplified in high-stress environments like prisons and economically deprived communities.

But the evidence is unambiguous: synthetic cannabinoids do not effectively treat stress. They create a short window of perceived relief followed by escalating psychological and physical harm, addiction, and in many cases, life-threatening emergencies. The European Union Drugs Agency and multiple peer-reviewed studies confirm that these substances represent one of the most serious drug safety threats in Europe today.

If you or someone you know is using synthetic cannabinoids to manage stress, the most important step is to seek proper mental health support. For authoritative, evidence-based information on synthetic cannabinoids and drug policy across Europe, visit the European Union Drugs Agency (EUDA) Synthetic Cannabinoids resource page.

📚 Related Reading

Want to learn more about drug safety, mental health, and harm reduction in Europe? Explore our related articles on understanding new psychoactive substances in Europe, evidence-based approaches to stress and anxiety, and how the EU Early Warning System tracks drug threats.

📎 Sources & References

1. European Union Drugs Agency (EUDA). Synthetic Cannabinoids in Europe — Perspectives on Drugs. euda.europa.eu
2. EUDA. New Psychoactive Substances — European Drug Report 2025. euda.europa.eu
3. Alzu’bi A, et al. The Synthetic Cannabinoids Menace: A Review of Health Risks and Toxicity. European Journal of Medical Research, 2024. PMC10785485
4. Cannabis and Synthetic Cannabinoids Are Used for Different Reasons. International Journal of Mental Health and Addiction, Springer Nature, June 2025.
5. Teixeira HM, et al. Phytocannabinoids and Synthetic Cannabinoids: From Recreational Consumption to Potential Therapeutic Use. Frontiers in Toxicology, January 2025.
6. EUDA. European Drug Report 2024: Trends and Developments. emcdda.europa.eu, June 2024.
7. Cleveland Clinic. The Dangerous Effects of Synthetic Weed. health.clevelandclinic.org, 2026.